The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution
- PMID: 10100542
- DOI: 10.1086/501606
The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution
Abstract
Objective: To study vancomycin-resistant Enterococcus (VRE) prevalence, risk factors, and clustering among hospital inpatients.
Design: Rectal-swab prevalence culture survey conducted from February 5 to March 22, 1996.
Setting: The Veterans' Affairs Medical Center, Atlanta, Georgia.
Patients: Hospital (medical and surgical) inpatients.
Results: The overall VRE prevalence was 29% (42/147 patients). The VRE prevalence was 52% (38/73 patients) among patients who had received at least one of six specific antimicrobials during the preceding 120 days, compared with only 5% (4/74) among those who had not received the antimicrobials (relative risk, 9.6; P<.001). The longer the period (up to 120 days) during which antimicrobial use was studied, the more closely VRE status was predicted. Among 67 hospital patients in 28 multibed rooms, clustering of VRE among current roommates was not found.
Conclusions: At this hospital with relatively high VRE prevalence, VRE colonization was related to antibiotic use but not to roommate VRE status. In hospitals with a similar VRE epidemiology, obtaining cultures from roommates of VRE-positive patients may not be as efficient a strategy for identifying VRE-colonized patients as obtaining screening cultures from patients who have received antimicrobials.
Similar articles
-
Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital.Infect Control Hosp Epidemiol. 2008 May;29(5):398-403. doi: 10.1086/587187. Infect Control Hosp Epidemiol. 2008. PMID: 18419360
-
Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.Am J Infect Control. 2009 Nov;37(9):734-40. doi: 10.1016/j.ajic.2008.09.025. Epub 2009 Feb 1. Am J Infect Control. 2009. PMID: 19188004
-
Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.Infect Control Hosp Epidemiol. 2008 May;29(5):404-9. doi: 10.1086/587647. Infect Control Hosp Epidemiol. 2008. PMID: 18419361
-
Vancomycin resistant enterococci healthcare associated infections.Ann Ig. 2013 Nov-Dec;25(6):485-92. doi: 10.7416/ai.2013.1948. Ann Ig. 2013. PMID: 24284534 Review.
-
Vancomycin-resistant enterococci: 15 years and counting.J Hosp Infect. 2003 Mar;53(3):159-71. doi: 10.1053/jhin.2002.1375. J Hosp Infect. 2003. PMID: 12623315 Review.
Cited by
-
Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci.Antimicrob Agents Chemother. 2002 Jun;46(6):1619-28. doi: 10.1128/AAC.46.6.1619-1628.2002. Antimicrob Agents Chemother. 2002. PMID: 12019066 Free PMC article. Review. No abstract available.
-
Vancomycin-resistant enterococci in Canada revisited.Can J Infect Dis. 2000 May;11(3):127-31. doi: 10.1155/2000/626047. Can J Infect Dis. 2000. PMID: 18159277 Free PMC article. No abstract available.
-
Relationships between enterococcal virulence and antimicrobial resistance.Clin Microbiol Rev. 2000 Oct;13(4):513-22. doi: 10.1128/CMR.13.4.513. Clin Microbiol Rev. 2000. PMID: 11023953 Free PMC article. Review.
-
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.Am J Infect Control. 2007 Dec;35(10 Suppl 2):S65-164. doi: 10.1016/j.ajic.2007.10.007. Am J Infect Control. 2007. PMID: 18068815 Free PMC article. No abstract available.
-
Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.Antimicrob Agents Chemother. 2003 Aug;47(8):2492-8. doi: 10.1128/AAC.47.8.2492-2498.2003. Antimicrob Agents Chemother. 2003. PMID: 12878510 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical